Research Reports on Top Traded Penny Stocks: Hanmi Financial, Geron, Towerstream, BioSante, Syntroleum & Sunwin
Pennystocksinsiders.com (PSI) has issued insider trading reports and Equity Research for the following companies: Hanmi Financial (NASDAQ:HAFC), Geron (NASDAQ:GERN), Towerstream (NASDAQ:TWER), BioSante (NASDAQ:BPAX), Syntroleum (NASDAQ:SYNM) & Sunwin (OTC:SUWN).
Investors can easily trade penny stocks online now. Many online stock brokers provide free equity research reports for their clients; however, none of them provide insider trading research reports. Penny stock companies are lack of transparency and almost no investment firm research analysts regularly issue research reports for penny stocks. Monitor the insider trading activities may be the only way to find out more information about penny stock company's real financial situation.
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
Hanmi Financial Corp (NASDAQ:HAFC): Stock price dropped over 8% on Nov 15, 2011 on heavier than usual volume. Why? Did insiders like CEO, CFO, and Directors sold their shareholdings before the stock price dropped? Is EMIS A Scam? Check out the insider trade report here. Read Full Report: http://www.Pennystocksinsiders.com/PR/111611A/HAFC/HanmiFinancial.pdf
Geron Corporation (NASDAQ:GERN): GERN is down $0.43 at $1.77, a loss of 19.55%. Shares of Geron fell this morning after the company said it would drop stem cells and focus on cancer. The company will also cut 66 jobs. Check out the latest report here. Read Full Report: http://www.Pennystocksinsiders.com/PR/111611A/GERN/Geron.pdf
Towerstream Corporation (NASDAQ:TWER): Observed abnormal increase in trade volume. Over 3.71 million shares traded on Nov 15, 2011 which was 10 times higher than the average trade volume. TWER reported Q3 EPS of ($0.05), 1 cent worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $6.78 million versus the consensus estimate of $6.8 million. Towerstream sees Q4 2011 revenue of $7.0 to $7.1 million, versus the consensus of $7.25 million; see if CEO, CFO, and Directors in POSC are trading the stock now. Read Full Report: http://www.Pennystocksinsiders.com/PR/111611A/TWER/Towerstream.pdf
Today Pennystocksinsiders.com released other research reports for:
BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX):
Read Full Report: http://www.Pennystocksinsiders.com/PR/111611A/BPAX/BioSante.pdf
Syntroleum Corp (NASDAQ:SYNM):
Read Full Report: http://www.Pennystocksinsiders.com/PR/111611A/SYNM/Syntroleum.pdf
Sunwin International Neutraceuticals Inc (OTC:SUWN):
Read Full Report: http://www.Pennystocksinsiders.com/PR/111611A/SUWN/Sunwin.pdf
More Individual Stock Reports & Sector Reports:
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
Pennystocksinsiders.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
Please visit http://www.Pennystocksinsiders.com/disclaimers/index.php for details.
CONTACT: Pennystocksinsiders.com, support@Pennystocksinsiders.com, +1-778-2976120
Reported on Nov 16, 2011
More Insider News ...